leisure time
Previous article:
Moonlake's readout produced a cash windfall. Risks remain
Next article: A single drug, study failures leave Anavex with nothing but cash
Next article: A single drug, study failures leave Anavex with nothing but cash
leisure time
hotspot
-
How a scoliosis diagnosis changed the life of one young dancer
2025-10-04 03:49 -
J&J to buy cancer drug developer Ambrx Biopharma
2025-10-04 03:33 -
U.K. sequencing study surfaces new findings about tumor DNA
2025-10-04 03:18 -
Researchers on aging grapple with how to calculate biological age
2025-10-04 03:14 -
Sanofi strikes deal with Novavax, boosting the vaccine maker
2025-10-04 02:12 -
Videos point to link between seizures and unexplained toddler deaths
2025-10-04 01:34